review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1038/NRGASTRO.2011.91 |
P698 | PubMed publication ID | 21629239 |
P50 | author | David Sanders | Q71501508 |
P2093 | author name string | Kofi Oppong | |
John S Leeds | |||
P2860 | cites work | Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test | Q24541364 |
The molecular genetics of familial intrahepatic cholestasis | Q24670001 | ||
Towards positive diagnosis of the irritable bowel | Q24674701 | ||
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum | Q28117412 | ||
ICA69 is expressed equally in the human endocrine and exocrine pancreas | Q28288007 | ||
Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus | Q33803443 | ||
Prospective study of body mass index in patients with coeliac disease | Q33853320 | ||
Diagnosis of chronic pancreatitis: Functional testing. | Q34118008 | ||
Pancreatic function in Crohn's disease | Q34392975 | ||
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study | Q34531167 | ||
14C triolein breath test: a routine test in the gastroenterology clinic? | Q34531706 | ||
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England | Q34534431 | ||
The many faces of celiac disease: clinical presentation of celiac disease in the adult population | Q34556706 | ||
The functional gastrointestinal disorders and the Rome III process | Q34567301 | ||
Association of pancreatitis with glucagon-like peptide-1 agonist use. | Q34618507 | ||
Pancreatic insufficiency in celiac disease is not dependent on nutritional status | Q72714111 | ||
Structure/activity characterization of glucagon-like peptide-1 | Q72797008 | ||
Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal | Q72999202 | ||
The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency | Q73401137 | ||
A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group | Q73402165 | ||
The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet | Q73403963 | ||
Pancreatic elastase 1 in stool: variations within one stool passage and individual changes from day to day | Q73481456 | ||
Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus | Q73690722 | ||
Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity | Q73932422 | ||
Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease | Q73942569 | ||
Regional enteritis: associated visceral changes | Q73965158 | ||
Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology | Q74049536 | ||
Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea | Q74160907 | ||
Exocrine pancreatic insufficiency in celiac disease | Q74298257 | ||
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test | Q74456840 | ||
Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus | Q74467308 | ||
The pathologic effects of large amounts of glucagon | Q74491866 | ||
Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis | Q74494123 | ||
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care | Q77160925 | ||
Basal and fat-stimulated plasma peptide YY levels in celiac disease | Q77195232 | ||
Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn's disease and ulcerative colitis | Q77527090 | ||
Influence of jejunal morphology changes on exocrine pancreatic function in celiac disease | Q77983779 | ||
The effect of protracted glucagon administration on blood glucose and on pancreatic morphology | Q78324091 | ||
PATHOGENESIS OF ACUTE AND CHRONIC PANCREATITIS | Q78383988 | ||
Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis | Q78582128 | ||
Exocrine dysfunction of the pancreas in patients with chronic polyarthritis | Q79235260 | ||
Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease | Q79923186 | ||
Now that fecal elastase is available in the United States, should clinicians start using it? | Q80189282 | ||
Magnetic resonance imaging and magnetic resonance cholangiopancreatography findings compared with fecal elastase 1 measurement for the diagnosis of chronic pancreatitis | Q80487509 | ||
[Pancreatic exocrine function in diabetes mellitus. Determination of fecal elastase] | Q83939880 | ||
Pancreatic functional impairment following acute necrotizing pancreatitis: long-term outcome of a non-surgically treated series | Q84738834 | ||
Guidelines on the irritable bowel syndrome: mechanisms and practical management. | Q34626602 | ||
Modern diagnostics of chronic pancreatitis | Q34916418 | ||
Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region | Q35349077 | ||
Pancreatic dysfunction and its association with fat malabsorption in HIV infected children | Q35352447 | ||
Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire | Q35513015 | ||
Diagnosis and management of chronic pancreatitis | Q35522501 | ||
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome | Q35579339 | ||
Determinants of Exocrine Pancreatic Function as Measured by Fecal Elastase-1 Concentrations (FEC) in Patients with Diabetes mellitus | Q35959442 | ||
The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland | Q36587714 | ||
Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? | Q37069949 | ||
Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia | Q37111867 | ||
Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects? | Q37386584 | ||
Etiology of nonresponsive celiac disease: results of a systematic approach | Q38856457 | ||
The pancreatic secretion in the malabsorption syndrome and related malnutrition states. | Q38977912 | ||
Pancreatic exocrine insufficiency in HIV-positive patients | Q39129728 | ||
Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure. | Q39390048 | ||
Review article: management of patients with non-responsive coeliac disease | Q41194256 | ||
Association of chronic alcoholic liver and pancreatic disease: a prospective study | Q41507287 | ||
Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis. | Q42528483 | ||
Involvement of the pancreas in AIDS: a prospective study of 109 post-mortems | Q42634239 | ||
Purification and characterization of a cholesterol-binding protein from human pancreas | Q42868966 | ||
Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency | Q43087694 | ||
Incidence, prevalence, etiology, and prognosis of first-time chronic pancreatitis in young patients: a nationwide cohort study | Q43182263 | ||
Prevalence of gastrointestinal symptoms in the elderly: a population-based study | Q43310431 | ||
Low faecal elastase 1 concentrations in type 2 diabetes mellitus | Q43758373 | ||
Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests? | Q43758387 | ||
Low fecal elastase-1 in type I diabetes mellitus | Q43769283 | ||
Impaired cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue | Q43786531 | ||
Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease? | Q44089824 | ||
Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german population | Q44178215 | ||
Exocrine pancreatic function and fat malabsorption in human immunodeficiency virus-infected patients | Q44564926 | ||
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients | Q44606689 | ||
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study | Q44618783 | ||
A primary care cross-sectional study of undiagnosed adult coeliac disease | Q44650499 | ||
Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus | Q44700985 | ||
Exocrine function following the whipple operation as assessed by stool elastase | Q44924864 | ||
Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? | Q45048428 | ||
Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy | Q45846771 | ||
Exocrine pancreatic function in Sjögren's syndrome. | Q45992986 | ||
Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal elastase 1 deficiency. | Q46202908 | ||
The size of the pancreas in diabetes mellitus | Q47387248 | ||
A study of pancreatic function among subjects over ninety years of age. | Q47904108 | ||
The incidence and clinical relevance of chronic inflammation in the pancreas in autopsy material | Q50148878 | ||
Usefulness of faecal elastase-1 assay in monitoring pancreatic function in childhood coeliac disease. | Q50855043 | ||
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance. | Q51465919 | ||
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. | Q51472489 | ||
Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. | Q51485588 | ||
Comparison of endoscopic retrograde cholangiopancreatography, endoscopic ultrasonography, and fecal elastase 1 in chronic pancreatitis and clinical correlation. | Q51650489 | ||
Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. | Q51712043 | ||
Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. | Q52488742 | ||
Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. | Q52848817 | ||
Risk of pancreatitis in patients with celiac disease: is autoimmune pancreatitis a biologically plausible mechanism? | Q52851132 | ||
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? | Q52854508 | ||
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders | Q52860277 | ||
Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients. | Q53885774 | ||
ICA69 is expressed equally in the human endocrine and exocrine pancreas | Q56601171 | ||
Exocrine pancreatic function in patients with end-stage renal disease | Q56779266 | ||
Exocrine pancreatic function during the early recovery phase of acute pancreatitis | Q56990718 | ||
Impaired fecal elastase excretion in uremic pancreopathy | Q57009077 | ||
Prevalence and determinants of exocrine pancreatic insufficiency among older adults: Results of a population-based study | Q57192560 | ||
Pancreatic Autoantibodies in Inflammatory Bowel Disease | Q57265453 | ||
Prevalence of Pancreatic Insufficiency in Inflammatory Bowel Diseases. Assessment by Fecal Elastase-1 | Q57971998 | ||
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution | Q58168549 | ||
Pancreatic Exocrine Function Tests | Q60023636 | ||
Monoclonal versus Polyclonal ELISA for Assessment of Fecal Elastase Concentration: Pitfalls of a New Assay | Q61908110 | ||
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function | Q61908173 | ||
Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus | Q67666391 | ||
Exocrine pancreatic function in chronic liver diseases | Q67680935 | ||
The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients | Q68015945 | ||
Treatment failure in celiac disease due to coexistent exocrine pancreatic insufficiency | Q69454898 | ||
Functional reserve capacity of the exocrine pancreas | Q69662143 | ||
Use of the triolein breath test in alcoholics with liver damage | Q69695993 | ||
Ultrasonographic abnormalities of the pancreas in IDDM and NIDDM patients | Q70492178 | ||
Enteropathy associated with the acquired immunodeficiency syndrome | Q70609075 | ||
Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study | Q70823749 | ||
TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes | Q70881995 | ||
Chronic pancreatitis prevalence in liver cirrhosis. Morphological and functional study | Q71470742 | ||
Steatorrhea: a common manifestation in patients with HIV/AIDS | Q71699956 | ||
Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis | Q71835873 | ||
[Evaluation of exocrine pancreatic insufficiency in cirrhotic patients,using the fecal chymotrypsin test] | Q71988588 | ||
Influence of glucagon on pancreatic exocrine secretion | Q72343475 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | feces | Q496 |
P304 | page(s) | 405-415 | |
P577 | publication date | 2011-05-31 | |
P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
P1476 | title | The role of fecal elastase-1 in detecting exocrine pancreatic disease | |
P478 | volume | 8 |
Q58564354 | Challenges in the management of pancreatic exocrine insufficiency |
Q35858172 | Change of Both Endocrine and Exocrine Insufficiencies After Acute Pancreatitis in Non-Diabetic Patients: A Nationwide Population-Based Study |
Q50939105 | Detection of human elastase isoforms by the ScheBo Pancreatic Elastase 1 Test. |
Q34386682 | Diagnosis and treatment of pancreatic exocrine insufficiency |
Q85383136 | Diagnosis of Exocrine Pancreatic Insufficiency |
Q42617501 | Endocrine and exocrine pancreatic insufficiency after acute pancreatitis: long-term follow-up study. |
Q64239358 | Exocrine pancreatic function is preserved in systemic sclerosis |
Q40814432 | Exocrine pancreatic insufficiency and diabetes mellitus |
Q60921474 | Fecal Elastase Levels Predict Honeycombing in Pancreas Detected with Endoscopic Ultrasound |
Q38159436 | Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives. |
Q43375819 | Influence of SPK with Enteric Drainage on the Pancreatic Exocrine Function in Diabetic Patients with Uremia |
Q48099475 | Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician |
Q36226381 | Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults. |
Q45914147 | Less common etiologies of exocrine pancreatic insufficiency. |
Q30457747 | Pancreatic enzyme replacement therapy during pancreatic insufficiency |
Q47096424 | Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss. |
Q54971828 | Pancreatic function following post-endoscopic retrograde cholangiopancreatography pancreatitis: A controlled cohort study with long-term follow-up. |
Q30456611 | Pancreatic surgery: indications, complications, and implications for nutrition intervention |
Q36184845 | Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency |
Q39185556 | Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. |
Q26828574 | Purinergic signalling and diabetes |
Q33754415 | Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition |
Q50890445 | Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates. |
Q28596642 | The cystic fibrosis lower airways microbial metagenome |
Q47652853 | The role of complementary and alternative medicine for pancreatic disorders |
Q85725459 | [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus] |